As of Q4'25, BBAI's latest operating expenses show R&D Expenses at USD 4.8M and SG&A Expenses at USD 25.7M. This marks the highest level for both categories within the observed period, indicating a significant increase in spending at the end of 2025. From Q1'23 to Q4'25, the chart reveals considerable volatility in R&D Expenses, including a notable dip into negative territory in Q3'23, followed by a steady upward trend peaking in Q4'25. SG&A Expenses, while fluctuating, generally remain much higher than R&D, with a pronounced spike in Q2'24 and a strong upward movement in the latter half of 2025. Overall, the data suggests increasing investment in both research and administrative functions, with SG&A consistently dominating the expense structure throughout the period.